Home › NDC Lookup › RxCUI directory › RxCUI 1605074

0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe — RxCUI 1605074

RxNorm drug concept · Semantic clinical drug
RxCUI 1605074 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1605074
Official name0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfilgrastim-sndz 480 MCG per 0.8 ML Prefilled Syringe; filgrastim-sndz 480 MCG in 0.8 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped8
Reported Medicaid activity (SDUD)9,563 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Filgrastim Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Filgrastim tells your bone marrow to make more neutrophils, which are the white blood cells that fight off bacterial infections. When chemotherapy or a condition like chronic neutr...
  • Why has my doctor prescribed filgrastim — what does it actually do for me?
  • The most common one is bone pain — it can range from mild achiness to more noticeable discomfort, especially in your back, hips, or legs, and it's more pronounced when filgrastim i...
  • What side effects are most likely, and are they serious?
📖 Read our full Filgrastim Injection guide →

🕸️ Concept Web — How 0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe RxCUI 1605074

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Filgrastim 68442
    • Filgrastim-sndz 1605064
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zarxio 1605067
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Filgrastim Prefilled Syringe 727534
    • Filgrastim-sndz Prefilled Syringe 2646001
    • Filgrastim Injectable Product 1159651
    • Filgrastim-sndz Injectable Product 2661874
    • Filgrastim Prefilled Syringe [Zarxio] 1605069
    • Filgrastim-sndz Prefilled Syringe [Zarxio] 2654613
    • Zarxio Injectable Product 1605070
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Filgrastim-sndz 0.6 MG/ML SCDC · 1605065
  • Filgrastim Prefilled Syringe SCDF · 727534
  • Filgrastim-sndz Prefilled Syringe SCDFP · 2646001
  • Filgrastim Injectable Product SCDG · 1159651
  • Filgrastim-sndz Injectable Product SCDGP · 2661874

Brand-Name Concepts

  • 0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] SBD · 1605075
  • Filgrastim-sndz 0.6 MG/ML [Zarxio] SBDC · 1605068
  • Filgrastim Prefilled Syringe [Zarxio] SBDF · 1605069
  • Filgrastim-sndz Prefilled Syringe [Zarxio] SBDFP · 2654613
  • Zarxio Injectable Product SBDG · 1605070
  • Zarxio BN · 1605067

📦 FDA Products & Package NDCs

2 products · 8 package NDCs
8 package NDCs map to RxCUI 1605074 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61314-0318-01 1 BLISTER PACK in 1 CARTON (61314-318-01) / 1 SYRINGE in 1... ZARXIO Sandoz Inc. 2018-02-22
61314-0318-10 2 BLISTER PACK in 1 CARTON (61314-318-10) / 5 SYRINGE in 1... ZARXIO Sandoz Inc. 2018-02-22
61314-0318-63 1 BLISTER PACK in 1 CARTON (61314-318-63) / 1 SYRINGE in 1... ZARXIO Sandoz Inc. 2026-06-12
61314-0318-69 2 BLISTER PACK in 1 CARTON (61314-318-69) / 5 SYRINGE in 1... ZARXIO Sandoz Inc. 2026-06-12
61314-0326-01 1 BLISTER PACK in 1 CARTON (61314-326-01) / 1 SYRINGE in 1... ZARXIO Sandoz Inc. 2018-02-22
61314-0326-10 2 BLISTER PACK in 1 CARTON (61314-326-10) / 5 SYRINGE in 1... ZARXIO Sandoz Inc. 2018-02-22
61314-0326-63 1 BLISTER PACK in 1 CARTON (61314-326-63) / 1 SYRINGE in 1... ZARXIO Sandoz Inc. 2026-06-12
61314-0326-69 2 BLISTER PACK in 1 CARTON (61314-326-69) / 5 SYRINGE in 1... ZARXIO Sandoz Inc. 2026-06-12
Observed labelers: Sandoz Inc. (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5101 Injection, zarxio 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.